HOME >> MEDICINE >> NEWS
Imatinib shows early promise against Ewings sarcoma

Imatinib mesylate, also known as Gleevec, is showing early signs of promise in preclinical trials against Ewing's sarcoma, a bone tumor in children and adolescents. In a study in the November 20 issue of the Journal of the National Cancer Institute, treatment with imatinib induced cell death in all Ewing's sarcoma cell lines tested and substantial tumor shrinkage in mice.

Imatinib is a tyrosine kinase inhibitor that has produced high response rates in patients with chronic myelogenous leukemia and gastrointestinal stromal tumors. Both cancers are associated with the overactivation of a specific tyrosine kinase. In Ewing's sarcoma, overactivation of the c-kit receptor tyrosine kinase contributes to tumor growth and tumor cell proliferation.

Melinda S. Merchant, M.D., Ph.D., of the National Cancer Institute, and her colleagues examined whether imatinib inhibited tumor growth and cell proliferation of Ewing's sarcoma by testing the drug in 10 mice bearing human Ewing's sarcoma tumors and in 10 Ewing's sarcoma cell lines.

Treatment with imatinib caused cell death in all cell lines tested, including those resistant to chemotherapy. "This observation is especially important because chemoresistance is a major contributor to the rate of treatment failure in recurrent Ewing's sarcoma," the authors say. Treatment with imatinib also blocked activation of the c-kit receptor tyrosine kinase and resulted in substantial tumor shrinkage in mice bearing human Ewing's sarcoma tumors.

The authors note that higher concentrations of imatinib were needed to kill Ewing's sarcoma cells than other tumor cells but that "even if the toxicity of higher doses of imatinib proves intolerable for clinical translation of these results, the identification of the target or targets of imatinib that lead to cytotoxicity in Ewing's sarcoma may allow the design of related compounds with increased specificity to induce death of Ewing's sarcoma cells." '"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
19-Nov-2002


Page: 1 2

Related medicine news :

1. Imatinib (Gleevec) has activity in AIDS-related Kaposis sarcoma
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Chronic pain treatments more effective when taken together, new study shows
6. UW study shows blacks and Latinos are more satisfied with physicians of the same race
7. Vaccine against childhood pneumonia shows promise
8. UW research shows risk factors for relapse among health care professionals who abuse drugs
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. New technique shows promise for improved straightening of crooked nose
11. Chemical decoy shows promise for slowing Alzheimers by acting as decoy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... The American Medical ... Wednesday, April 7, to Saturday, April 10, 2021, at Wynn Las Vegas. The ... a national trade show for non-invasive medical aesthetic practices that brings together owners, ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... it has completed $3 million convertible note financing, which will be used to ... With the funds from this financing, the company will continue to expand its ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma Research ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... of Blood Cancer Awareness Month (BCAM) and its international Light it Red ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State ... high-quality, career-relevant, and affordable online education – is proud to announce its new ... the first of its kind in the nation, the 60-credit hour program is ...
(Date:8/31/2020)... ... 2020 , ... Dr. Chang has over 20 years of ... developmental disabilities, as well as supporting staff in caring for patients and families. ... and staff development. She joined the company in 2015 as Chief of Clinical ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... (PRWEB) , ... September 02, 2020 , ... ... 1064nm Raman technology, will moderate a roundtable discussion among industry professionals about successes ... will be hosted by American Pharmaceutical Review and will take place ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... and Director of Cosmetics and Laser Surgery at the University of Rochester Medical ... Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from the Harvard ...
(Date:9/1/2020)... , ... September 01, 2020 , ... September is National ... accounting for more deaths than any other cancer of the female reproductive system. ... with ovarian cancer and about 14,000 women will die from this disease. Throughout ...
Breaking Medicine Technology:
Cached News: